Overcoming Ceftaroline Resistance in MRSA Using Ceftaroline–Carbapenem Combination Therapy - Takeaways - MDSpire

Overcoming Ceftaroline Resistance in MRSA Using Ceftaroline–Carbapenem Combination Therapy

  • By

  • Joshua Olson

  • Valliammai Alaguvel

  • Gabriel Pérez-Parra

  • Allen Jankeel

  • Anuj K Khetarpal

  • Valeria Rodríguez-Guevara

  • Vanessa Vu

  • George Sakoulas

  • Erlinda R Ulloa

  • January 20, 2026

  • 0 min

Share

  • 1

    Ceftaroline-resistant MRSA presents a growing therapeutic challenge in treating persistent infections like bacteremia and endocarditis.

  • 2

    Combining ceftaroline with carbapenems has been shown to restore antimicrobial activity against resistant MRSA strains in vitro and in murine models.

  • 3

    Ceftaroline targets penicillin-binding protein 2a, but resistance driven by mecA and PBP mutations threatens its efficacy.

  • 4

    The study suggests that combination therapy may effectively suppress resistance and enhance immune-mediated killing against MRSA.

  • 5

    Further clinical investigation is warranted to explore the potential of ceftaroline-carbapenem therapy for difficult MRSA infections.

Original Source(s)

Overcoming Ceftaroline Resistance in MRSA Using Ceftaroline–Carbapenem Combination Therapy

  • by Joshua Olson, Valliammai Alaguvel, Gabriel Pérez-Parra, Allen Jankeel, Anuj K Khetarpal, Valeria Rodríguez-Guevara, Vanessa Vu, George Sakoulas, Erlinda R Ulloa

  • January 20, 2026

Related Content

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Geospatial and Temporal Assessment of Tuberculosis Incidence in Iran

Is “Against Medical Advice” Still Defensible?

A Viewpoint calls for more dignifying, harm-reduction–oriented hospital discharges for patients with OUD.